Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Akorn, Inc.
Akorn Amplifies Form 8-K Disclosure
March 13th, 2009
Akorn, Inc. (NASDAQ: AKRX) today amplified its Form 8-K Regulation FD Disclosure filed with the Securities and Exchange Commission today. The Form 8-K reports that the Company is currently restricted from any further borrowings against its Revolver with General Electric Capital Corporation (GECC), although the Company may maintain its current outstanding balance as of February 19, 2009. The Company is evaluating all its business segments and working towards a positive resolution of its working capital needs. Dr. Kapoor, Akorn’s Chairman of the Board commented, “Akorn operates in a highly competitive environment, which has been further adversely impacted by current...
Source: Health Business Week (2009-03-13)
|
